Protalix BioTherapeutics (PLX) Cash & Equivalents (2010 - 2026)
Protalix BioTherapeutics (PLX) reported Cash & Equivalents of $27.42 million for Q2 2026, up 53.2% from $17.9 million a year earlier but down 33.1% from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Protalix BioTherapeutics posted Cash & Equivalents of $14.68 million, down 25.7% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -4.3% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $19.76 million in FY2024 (-16.4%), $23.63 million in FY2023 (+38.1%), $17.11 million in FY2022 (-56.1%) and $38.99 million in FY2021 (+113.4%).
- Five-year quarterly Cash & Equivalents spans a low of $10.64 million in Q3 2021 and a high of $48.18 million in Q2 2023.
- Year over year, Cash & Equivalents gained in three of the last eight quarters, with growth averaging 6.7%.
- The high point for year-over-year Cash & Equivalents in five years was Q2 2023 (growth of 285.7%); the low point was Q2 2022 (a decline of 63.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $41 million (Q1 2026), $14.68 million (Q4 2025) and $13.65 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Protalix BioTherapeutics | 204.37 Mn | 52.98 Mn | 12.13 Mn | 27.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.42 Mn |
| Mar 31, 2026 | 41.00 Mn |
| Dec 31, 2025 | 14.68 Mn |
| Sep 30, 2025 | 13.65 Mn |
| Jun 30, 2025 | 17.90 Mn |
| Mar 31, 2025 | 19.46 Mn |
| Dec 31, 2024 | 19.76 Mn |
| Sep 30, 2024 | 27.41 Mn |
| Jun 30, 2024 | 23.40 Mn |
| Mar 31, 2024 | 27.21 Mn |
| Dec 31, 2023 | 23.63 Mn |
| Sep 30, 2023 | 20.41 Mn |
| Jun 30, 2023 | 48.18 Mn |
| Mar 31, 2023 | 33.04 Mn |
| Dec 31, 2022 | 17.11 Mn |
| Sep 30, 2022 | 10.72 Mn |
| Jun 30, 2022 | 12.49 Mn |
| Mar 31, 2022 | 16.89 Mn |
| Dec 31, 2021 | 38.99 Mn |
| Sep 30, 2021 | 10.64 Mn |
API Access
Protalix BioTherapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();